Thorsten Steiner Selected Research

idarucizumab

1/2020	Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.
12/2019	Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series.
5/2017	Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study.
1/2017	Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.
8/2015	Idarucizumab for Dabigatran Reversal.
7/2015	Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thorsten Steiner Research Topics

Disease

45	Cerebral Hemorrhage 10/2022 - 01/2005
36	Stroke (Strokes) 10/2022 - 02/2002
29	Hemorrhage 10/2022 - 02/2006
24	Ischemic Stroke 01/2020 - 03/2008
19	Hematoma 10/2022 - 01/2005
11	Hemorrhagic Stroke 01/2022 - 01/2009
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 01/2004
6	Atrial Fibrillation 10/2018 - 01/2007
4	Infarction (Infarctions) 06/2021 - 02/2002
4	Edema (Dropsy) 01/2021 - 01/2005
4	Infections 01/2020 - 01/2009
4	Patent Foramen Ovale 01/2019 - 01/2018
3	Transient Ischemic Attack 01/2018 - 01/2018
2	Coma (Comas) 01/2022 - 10/2006
2	Brain Injuries (Brain Injury) 01/2021 - 01/2009
2	COVID-19 01/2020 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 08/2015 - 01/2010
2	Hypothermia 08/2015 - 02/2002
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2012 - 02/2012
2	Hypertension (High Blood Pressure) 02/2010 - 01/2010
2	Atherosclerosis 01/2010 - 03/2008
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2010 - 02/2002
2	Body Weight (Weight, Body) 05/2008 - 02/2005
2	Brain Edema (Cerebral Edema) 01/2006 - 04/2002
2	Cerebral Infarction 01/2006 - 02/2005
1	Hyperglycemia 04/2022
1	Cerebral Palsy (Spastic Diplegia) 01/2020
1	Paresis (Hemiparesis) 01/2020
1	Subdural Hematoma (Subdural Hemorrhage) 12/2019
1	Embolism (Embolus) 09/2018
1	Wounds and Injuries (Trauma) 04/2016
1	Traumatic Cerebral Hemorrhage 01/2016
1	Hyperthermia 08/2015
1	Venous Thromboembolism 07/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2013
1	Heart Arrest (Cardiac Arrest) 03/2013
1	Seizures (Absence Seizure) 06/2012
1	Cerebrospinal Fluid Leak 06/2012

Drug/Important Bio-Agent (IBA)

27	AnticoagulantsIBA 01/2022 - 01/2006
12	recombinant FVIIa (rFVIIa)FDA Link 01/2022 - 01/2005
12	Vitamin K FDA Link 06/2021 - 01/2006
11	Factor VIIa (Activated Factor VII)IBA 01/2022 - 02/2005
11	Dabigatran FDA Link 01/2020 - 02/2014
8	Hemostatics (Antihemorrhagics)IBA 01/2021 - 01/2006
7	Factor VII (Proconvertin)IBA 01/2022 - 01/2005
7	N(4)-oleylcytosine arabinosideIBA 06/2021 - 02/2014
7	Warfarin (Coumadin)FDA LinkGeneric 12/2019 - 02/2006
6	idarucizumabIBA 01/2020 - 07/2015
5	Prothrombin (Factor II)IBA 12/2019 - 06/2011
4	Nicardipine (Dagan)FDA LinkGeneric 10/2022 - 01/2016
4	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2019
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2018 - 03/2007
4	prothrombin complex concentrates (PPSB)IBA 01/2017 - 01/2006
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 01/2008
3	RivaroxabanIBA 12/2019 - 02/2014
3	apixabanIBA 12/2019 - 02/2014
3	TESIBA 01/2016 - 03/2008
3	Pharmaceutical PreparationsIBA 10/2014 - 03/2008
3	Oxygen (Dioxygen)IBA 10/2011 - 04/2002
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 03/2007
2	Tranexamic Acid (AMCA)FDA Link 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	CreatinineIBA 10/2020 - 03/2007
2	Thrombin FDA Link 12/2019 - 10/2018
2	Factor Xa InhibitorsIBA 12/2019 - 10/2018
2	AntidotesIBA 12/2019 - 01/2016
2	Phenprocoumon (Liquamar)FDA Link 12/2019 - 06/2010
2	Hemoglobins (Hemoglobin)IBA 10/2011 - 01/2010
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Heparinoids (Heparinoid)IBA 01/2022
1	CytokinesIBA 01/2021
1	trioctyl phosphine oxide (TOPO)IBA 01/2021
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AcenocoumarolIBA 12/2019
1	edoxabanIBA 12/2019
1	2- ethyleneimino- 5,6,7,8- tetrahydronaphthoquinone (A 137)IBA 01/2017
1	AntipyreticsIBA 08/2015
1	EdaravoneIBA 01/2013
1	argatroban (MPQA)FDA Link 01/2013
1	Neuroprotective AgentsIBA 01/2013
1	Isoflurane FDA LinkGeneric 12/2012
1	Propofol (Diprivan)FDA LinkGeneric 12/2012
1	Midazolam (Versed)FDA LinkGeneric 12/2012
1	Lacosamide FDA Link 06/2012
1	Levetiracetam (Keppra)FDA LinkGeneric 06/2012
1	Antiviral Agents (Antivirals)IBA 04/2012

Therapy/Procedure

25	Therapeutics 01/2021 - 02/2002
6	Thrombectomy 01/2021 - 01/2016
6	Critical Care (Surgical Intensive Care) 01/2015 - 01/2004
4	Length of Stay 01/2020 - 01/2009
2	Surgical Decompression 06/2021 - 06/2021
2	Secondary Prevention 01/2019 - 10/2014
2	Anticoagulation Reversal 05/2017 - 02/2016
2	Induced Hypothermia 08/2015 - 03/2013
2	Tracheostomy 01/2013 - 02/2012
2	Catheters 06/2012 - 04/2002
2	Artificial Respiration (Mechanical Ventilation) 05/2011 - 01/2009
1	Operative Surgical Procedures 12/2018
1	Compression Stockings 10/2014